1,720,974 research outputs found

    La réduction des risques : évaluations et utilisation de la naloxone, de la buprénorphine long-acting, des salles de consommations et des prescriptions de prégabaline

    No full text
    Addiction is a behavioral disorder characterized by the pervasive repetition of behaviors associated with obtaining a reward and/or pleasure or relief. These behaviors often involve the use of psychoactive substances. One of the most significant advances in the field of 'modern' addiction medicine lies in the recognition of the importance of actively including patients/drug users in their own care. The main objective of my work has been to explore and assess the expectations and needs of users on different aspects: naloxone, long-acting buprenorphine, drug consumption rooms, and pregabalin prescriptions. To achieve this, several studies were conducted among professionals in the addiction field and drug users. These studies allowed, among other things, the evaluation of the naloxone usage rate in opioid overdoses, the preferences of patients (including those incarcerated) regarding a new injectable long-acting form of buprenorphine. Regarding drug consumption rooms, the study aimed to gather the opinions of users and identify profiles that would be most favorable. Finally, regarding pregabalin, the studies identified a profile of misusers and assessed the impact of a regulatory change regarding its prescription. By addressing these four subjects in this way, we present an original French mapping of the organization of care and harm reduction for users/patients with opioid and pregabalin use disorder.L'addiction est un trouble comportemental se manifestant par la répétition envahissante de comportements en lien avec l’obtention d’une récompense et/ou d’un plaisir ou d’un soulagement. Ces comportements concernent fréquemment l’usage de substances psychoactives. L'une des avancées les plus significatives dans le domaine de l'addictologie « moderne » réside dans la reconnaissance de l'importance de l'inclusion active des patients/usagers de drogues dans leur propre prise en charge. L’objectif principal de mon travail a été d’explorer et d’évaluer les attentes et besoins des usagers sur différents aspects : la naloxone, la buprénorphine long acting, les salles de consommation à moindre risque et les prescriptions de prégabaline. Pour ce faire, plusieurs études auprès des professionnels du champ addictologique, et des patients/usagers de drogues ont été menées. Ces études ont permis entre autres d’évaluer le taux d’usage de la naloxone dans les overdoses aux opioïdes et la préférence des patients (y compris incarcérés) vis à vis d’une nouvelle forme injectable à longue durée d’action de buprénorphine. Concernant la salle de consommation à moindre risque, l’étude visait à recueillir l’opinion des usagers et identifier les profils des usagers les plus intéressés. Enfin, concernant la prégabaline, la première étude a mis en évidence un profil de mésuseurs et la seconde a évalué l’impact d’une modification réglementaire concernant sa prescription. En abordant ainsi ces quatre sujets, on montre de manière originale une cartographie française sur l’organisation des soins et de la réduction des risques pour les usagers/patients souffrants d’un trouble d’usage des opioïdes et/ou de prégabaline

    Going Beyond Counting First Authors in Author Co-citation Analysis

    Full text link
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    La réduction des risques : évaluations et utilisation de la naloxone, de la buprénorphine long-acting, des salles de consommations et des prescriptions de prégabaline

    No full text
    Addiction is a behavioral disorder characterized by the pervasive repetition of behaviors associated with obtaining a reward and/or pleasure or relief. These behaviors often involve the use of psychoactive substances. One of the most significant advances in the field of 'modern' addiction medicine lies in the recognition of the importance of actively including patients/drug users in their own care. The main objective of my work has been to explore and assess the expectations and needs of users on different aspects: naloxone, long-acting buprenorphine, drug consumption rooms, and pregabalin prescriptions. To achieve this, several studies were conducted among professionals in the addiction field and drug users. These studies allowed, among other things, the evaluation of the naloxone usage rate in opioid overdoses, the preferences of patients (including those incarcerated) regarding a new injectable long-acting form of buprenorphine. Regarding drug consumption rooms, the study aimed to gather the opinions of users and identify profiles that would be most favorable. Finally, regarding pregabalin, the studies identified a profile of misusers and assessed the impact of a regulatory change regarding its prescription. By addressing these four subjects in this way, we present an original French mapping of the organization of care and harm reduction for users/patients with opioid and pregabalin use disorder.L'addiction est un trouble comportemental se manifestant par la répétition envahissante de comportements en lien avec l’obtention d’une récompense et/ou d’un plaisir ou d’un soulagement. Ces comportements concernent fréquemment l’usage de substances psychoactives. L'une des avancées les plus significatives dans le domaine de l'addictologie « moderne » réside dans la reconnaissance de l'importance de l'inclusion active des patients/usagers de drogues dans leur propre prise en charge. L’objectif principal de mon travail a été d’explorer et d’évaluer les attentes et besoins des usagers sur différents aspects : la naloxone, la buprénorphine long acting, les salles de consommation à moindre risque et les prescriptions de prégabaline. Pour ce faire, plusieurs études auprès des professionnels du champ addictologique, et des patients/usagers de drogues ont été menées. Ces études ont permis entre autres d’évaluer le taux d’usage de la naloxone dans les overdoses aux opioïdes et la préférence des patients (y compris incarcérés) vis à vis d’une nouvelle forme injectable à longue durée d’action de buprénorphine. Concernant la salle de consommation à moindre risque, l’étude visait à recueillir l’opinion des usagers et identifier les profils des usagers les plus intéressés. Enfin, concernant la prégabaline, la première étude a mis en évidence un profil de mésuseurs et la seconde a évalué l’impact d’une modification réglementaire concernant sa prescription. En abordant ainsi ces quatre sujets, on montre de manière originale une cartographie française sur l’organisation des soins et de la réduction des risques pour les usagers/patients souffrants d’un trouble d’usage des opioïdes et/ou de prégabaline

    Variations on the Author

    Full text link
    “Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship

    Appropriate Similarity Measures for Author Cocitation Analysis

    Full text link
    We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis

    Dispelling the Myths Behind First-author Citation Counts

    Full text link
    We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more sophisticated methods

    Author Index

    No full text
    Nao informado

    koamabayili/VECTRON-author-checklist: VECTRON author checklist

    No full text
    We have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
    corecore